Steven M. Kawut

Director, Pulmonary Hypertension/Pulmonary Vascular Disease Program · Penn Medicine

Credentials: · · · · · ·

History

Pulmonary Hypertension/Pulmonary Vascular Disease Program · Penn Medicine
Present
Penn Medicine
Present
Penn Medicine
Present

Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology
Review · Journal of the American College of Cardiology · 2013 · 822 citations
A global view of pulmonary hypertension
Review · The Lancet Respiratory Medicine · 2016 · 796 citations
Clinical risk factors for primary graft dysfunction after lung transplantation
American Journal of Respiratory and Critical Care Medicine · 2013 · 571 citations

Physical Activity in Pulmonary Arterial Hypertension (ACTiPH)
National Heart, Lung, and Blood Institute · R01
Contact PI · $5.6M · University of Pennsylvania
2021–2027
Case-Control Study of Methamphetamine in Pulmonary Arterial Hypertension
National Heart, Lung, and Blood Institute · R01
Contact PI · $3.7M · University of Pennsylvania
2021–2027
Novel Mechanisms of Hepatopulmonary Syndrome
National Heart, Lung, and Blood Institute · R01
Contact PI · $3.9M · University of Pennsylvania
2018–2025
Anastrozole in Pulmonary Arterial Hypertension (AIPH2) - CCC (Lead)
National Heart, Lung, and Blood Institute · R01
Contact PI · $5.5M · University of Pennsylvania
2017–2023

Pulmonary Hypertension and Anastrozole Trial
Principal investigator · Completed · Phase 2
University of Pennsylvania
2017–2022
Estrogen Receptor Antagonist in Patients With Pulmonary Arterial Hypertension
Principal investigator · Completed · Phase 2
University of Pennsylvania
2017–2018
Sorafenib for Hepatopulmonary Syndrome
Principal investigator · Terminated · Phase 2
University of Pennsylvania
2014–2018
Anastrozole in Patients With Pulmonary Arterial Hypertension
Principal investigator · Completed · Phase 2
University of Pennsylvania
2012–2015